Olanzapine and Pregnancy

This report focuses on the case of a pregnant woman with a bad obstetric history who developed psychosis at the 23 rd week of gestation. She was treated with olanzapine from the 24th week until 10 days prior to delivery. No adverse events occurred during pregnancy or delivery. The Apgar score was 8/10 at one minute and 9/10 at 5 minutes.

References

• 1 Asthuler L L, Cohen L, Szuba M, Ban V, Gitin M, Mintz J. Pharmacological management of psychiatric illness during pregnancy: dilemmas and guidelines.  Am J Psych. 1996;  153 592-606
• 2 Cohen L, Rosenbaum J F. Psychotropic drug use during pregnancy: weighing the risk.  J Clin Psychiatry. 1998;  59 (2) 18-28
• 3 Goldstein D J, Corbin L A, Fung M C. Olanzapine - exposed pregnancies and lactation early experience.  J Clin Psychopharmacol. 2000;  20 (4) 399-403
• 4 Kirchheiner J, Berghöfer A, Bolk-Weischedel D. Health outcome under olanzapine treatment in a pregnant woman.  Pharmacopsychiatry. 2000;  33 (2) 78-82
• 5 Nagy A, Tenyi T, Lenard K, Herold R, Wilhelm F, Trixler M. Olanzapine and pregnancy.  Orv Hetil. 2001;  142 (3) 137-138